Overview

Multiple Oral Doses of BIBR 1048 MS Solution in Healthy Volunteers

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To assess safety, pharmacokinetics and the effect of BIBR 1048 MS on coagulation parameters.
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Dabigatran